Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts

Qunzhou Zhang, Yidi Wu, David K. Ann, Diana V. Messadi, Tai Lan Tuan, A. Paul Kelly, Charles Bertolami, Anh D. Le

Research output: Contribution to journalArticle

Abstract

Keloids are an excessive accumulation of extracellular matrix. Although numerous studies have shown elevated plasminogen activator inhibitor-1 (PAI-1) levels in keloid fibroblasts compared with those of normal skin. Their specific mechanisms involved in the differential expression of PAI-1 in these cell types. In this study, the upregulation of PAI-1 expression is demonstrated in keloid tissues and their derived dermal fibroblasts, attesting to the persistence, if any, of fundamental differences between in vivo and in vitro paradigms. We further examined the mechanisms involved in hypoxia-induced regulation of PAI-1 gene in dermal fibroblast derived from keloid lesions and associated clinically normal peripheral skins from the same patient. Primary cultures were exposed to an environmental hypoxia or desferroxamine. We found that the hypoxia-induced elevation of PAI-1 gene appears to be regulated at both transcriptional and post-transcriptional levels in keloid fibroblasts. Furthermore, our results showed a consistent elevation of HIF-1α protein level in keloid tissues compared with their normal peripheral skin controls, implying a potential role as a biomarker for local skin hypoxia. Treatment with antisense oligonucleotides against hypoxia-inducible factor 1α (HIF-1α) led to the downregulation of steady-state levels of PAI-1 mRNA under both normoxic and hypoxic conditions. Conceivably, our results suggest that HIF-1α may be a novel therapeutic target to modulate the scar fibrosis process.

Original languageEnglish (US)
Pages (from-to)1005-1012
Number of pages8
JournalJournal of Investigative Dermatology
Volume121
Issue number5
DOIs
StatePublished - Nov 2003

Fingerprint

Keloid
Plasminogen Activator Inhibitor 1
Fibroblasts
Gene expression
Gene Expression
Hypoxia-Inducible Factor 1
Skin
Genes
Tissue
Deferoxamine
Antisense Oligonucleotides
Biomarkers
Cicatrix
Extracellular Matrix
Fibrosis
Up-Regulation
Down-Regulation
Messenger RNA
Hypoxia
Therapeutics

Keywords

  • Antisense
  • Desferroxamine
  • Half-life
  • HIF-1α
  • Hypoxia

ASJC Scopus subject areas

  • Dermatology

Cite this

Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts. / Zhang, Qunzhou; Wu, Yidi; Ann, David K.; Messadi, Diana V.; Tuan, Tai Lan; Kelly, A. Paul; Bertolami, Charles; Le, Anh D.

In: Journal of Investigative Dermatology, Vol. 121, No. 5, 11.2003, p. 1005-1012.

Research output: Contribution to journalArticle

Zhang, Qunzhou ; Wu, Yidi ; Ann, David K. ; Messadi, Diana V. ; Tuan, Tai Lan ; Kelly, A. Paul ; Bertolami, Charles ; Le, Anh D. / Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts. In: Journal of Investigative Dermatology. 2003 ; Vol. 121, No. 5. pp. 1005-1012.
@article{24b40526aa7b4a7e9ab5ab928eeb79d0,
title = "Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts",
abstract = "Keloids are an excessive accumulation of extracellular matrix. Although numerous studies have shown elevated plasminogen activator inhibitor-1 (PAI-1) levels in keloid fibroblasts compared with those of normal skin. Their specific mechanisms involved in the differential expression of PAI-1 in these cell types. In this study, the upregulation of PAI-1 expression is demonstrated in keloid tissues and their derived dermal fibroblasts, attesting to the persistence, if any, of fundamental differences between in vivo and in vitro paradigms. We further examined the mechanisms involved in hypoxia-induced regulation of PAI-1 gene in dermal fibroblast derived from keloid lesions and associated clinically normal peripheral skins from the same patient. Primary cultures were exposed to an environmental hypoxia or desferroxamine. We found that the hypoxia-induced elevation of PAI-1 gene appears to be regulated at both transcriptional and post-transcriptional levels in keloid fibroblasts. Furthermore, our results showed a consistent elevation of HIF-1α protein level in keloid tissues compared with their normal peripheral skin controls, implying a potential role as a biomarker for local skin hypoxia. Treatment with antisense oligonucleotides against hypoxia-inducible factor 1α (HIF-1α) led to the downregulation of steady-state levels of PAI-1 mRNA under both normoxic and hypoxic conditions. Conceivably, our results suggest that HIF-1α may be a novel therapeutic target to modulate the scar fibrosis process.",
keywords = "Antisense, Desferroxamine, Half-life, HIF-1α, Hypoxia",
author = "Qunzhou Zhang and Yidi Wu and Ann, {David K.} and Messadi, {Diana V.} and Tuan, {Tai Lan} and Kelly, {A. Paul} and Charles Bertolami and Le, {Anh D.}",
year = "2003",
month = "11",
doi = "10.1046/j.1523-1747.2003.12564.x",
language = "English (US)",
volume = "121",
pages = "1005--1012",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Mechanisms of Hypoxic Regulation of Plasminogen Activator Inhibitor-1 Gene Expression in Keloid Fibroblasts

AU - Zhang, Qunzhou

AU - Wu, Yidi

AU - Ann, David K.

AU - Messadi, Diana V.

AU - Tuan, Tai Lan

AU - Kelly, A. Paul

AU - Bertolami, Charles

AU - Le, Anh D.

PY - 2003/11

Y1 - 2003/11

N2 - Keloids are an excessive accumulation of extracellular matrix. Although numerous studies have shown elevated plasminogen activator inhibitor-1 (PAI-1) levels in keloid fibroblasts compared with those of normal skin. Their specific mechanisms involved in the differential expression of PAI-1 in these cell types. In this study, the upregulation of PAI-1 expression is demonstrated in keloid tissues and their derived dermal fibroblasts, attesting to the persistence, if any, of fundamental differences between in vivo and in vitro paradigms. We further examined the mechanisms involved in hypoxia-induced regulation of PAI-1 gene in dermal fibroblast derived from keloid lesions and associated clinically normal peripheral skins from the same patient. Primary cultures were exposed to an environmental hypoxia or desferroxamine. We found that the hypoxia-induced elevation of PAI-1 gene appears to be regulated at both transcriptional and post-transcriptional levels in keloid fibroblasts. Furthermore, our results showed a consistent elevation of HIF-1α protein level in keloid tissues compared with their normal peripheral skin controls, implying a potential role as a biomarker for local skin hypoxia. Treatment with antisense oligonucleotides against hypoxia-inducible factor 1α (HIF-1α) led to the downregulation of steady-state levels of PAI-1 mRNA under both normoxic and hypoxic conditions. Conceivably, our results suggest that HIF-1α may be a novel therapeutic target to modulate the scar fibrosis process.

AB - Keloids are an excessive accumulation of extracellular matrix. Although numerous studies have shown elevated plasminogen activator inhibitor-1 (PAI-1) levels in keloid fibroblasts compared with those of normal skin. Their specific mechanisms involved in the differential expression of PAI-1 in these cell types. In this study, the upregulation of PAI-1 expression is demonstrated in keloid tissues and their derived dermal fibroblasts, attesting to the persistence, if any, of fundamental differences between in vivo and in vitro paradigms. We further examined the mechanisms involved in hypoxia-induced regulation of PAI-1 gene in dermal fibroblast derived from keloid lesions and associated clinically normal peripheral skins from the same patient. Primary cultures were exposed to an environmental hypoxia or desferroxamine. We found that the hypoxia-induced elevation of PAI-1 gene appears to be regulated at both transcriptional and post-transcriptional levels in keloid fibroblasts. Furthermore, our results showed a consistent elevation of HIF-1α protein level in keloid tissues compared with their normal peripheral skin controls, implying a potential role as a biomarker for local skin hypoxia. Treatment with antisense oligonucleotides against hypoxia-inducible factor 1α (HIF-1α) led to the downregulation of steady-state levels of PAI-1 mRNA under both normoxic and hypoxic conditions. Conceivably, our results suggest that HIF-1α may be a novel therapeutic target to modulate the scar fibrosis process.

KW - Antisense

KW - Desferroxamine

KW - Half-life

KW - HIF-1α

KW - Hypoxia

UR - http://www.scopus.com/inward/record.url?scp=0242406744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242406744&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1747.2003.12564.x

DO - 10.1046/j.1523-1747.2003.12564.x

M3 - Article

C2 - 14708599

AN - SCOPUS:0242406744

VL - 121

SP - 1005

EP - 1012

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 5

ER -